BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

486 related articles for article (PubMed ID: 28377414)

  • 1. Diagnostic Distinction of Malignant Melanoma and Benign Nevi by a Gene Expression Signature and Correlation to Clinical Outcomes.
    Ko JS; Matharoo-Ball B; Billings SD; Thomson BJ; Tang JY; Sarin KY; Cai E; Kim J; Rock C; Kimbrell HZ; Flake DD; Warf MB; Nelson J; Davis T; Miller C; Rushton K; Hartman AR; Wenstrup RJ; Clarke LE
    Cancer Epidemiol Biomarkers Prev; 2017 Jul; 26(7):1107-1113. PubMed ID: 28377414
    [No Abstract]   [Full Text] [Related]  

  • 2. Clinical validation of a gene expression signature that differentiates benign nevi from malignant melanoma.
    Clarke LE; Warf MB; Flake DD; Hartman AR; Tahan S; Shea CR; Gerami P; Messina J; Florell SR; Wenstrup RJ; Rushton K; Roundy KM; Rock C; Roa B; Kolquist KA; Gutin A; Billings S; Leachman S
    J Cutan Pathol; 2015 Apr; 42(4):244-52. PubMed ID: 25727210
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An independent validation of a gene expression signature to differentiate malignant melanoma from benign melanocytic nevi.
    Clarke LE; Flake DD; Busam K; Cockerell C; Helm K; McNiff J; Reed J; Tschen J; Kim J; Barnhill R; Elenitsas R; Prieto VG; Nelson J; Kimbrell H; Kolquist KA; Brown KL; Warf MB; Roa BB; Wenstrup RJ
    Cancer; 2017 Feb; 123(4):617-628. PubMed ID: 27768230
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gene expression signature as an ancillary method in the diagnosis of desmoplastic melanoma.
    Clarke LE; Pimentel JD; Zalaznick H; Wang L; Busam KJ
    Hum Pathol; 2017 Dec; 70():113-120. PubMed ID: 29079183
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The usefulness of c-Kit in the immunohistochemical assessment of melanocytic lesions.
    Pilloni L; Bianco P; Difelice E; Cabras S; Castellanos ME; Atzori L; Ferreli C; Mulas P; Nemolato S; Faa G
    Eur J Histochem; 2011 Jun; 55(2):e20. PubMed ID: 22193299
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Development of a novel noninvasive adhesive patch test for the evaluation of pigmented lesions of the skin.
    Gerami P; Alsobrook JP; Palmer TJ; Robin HS
    J Am Acad Dermatol; 2014 Aug; 71(2):237-44. PubMed ID: 24906614
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Thermographic examination of cutaneous melanocytic nevi].
    Mikulska D
    Ann Acad Med Stetin; 2009; 55(1):31-8; discussion 38. PubMed ID: 20349589
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diagnostic significance of the blue hue in dermoscopy of melanocytic lesions: a dermoscopic-pathologic study.
    Massi D; De Giorgi V; Carli P; Santucci M
    Am J Dermatopathol; 2001 Oct; 23(5):463-9. PubMed ID: 11801781
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Beclin 1 and LC3 autophagic gene expression in cutaneous melanocytic lesions.
    Miracco C; Cevenini G; Franchi A; Luzi P; Cosci E; Mourmouras V; Monciatti I; Mannucci S; Biagioli M; Toscano M; Moretti D; Lio R; Massi D
    Hum Pathol; 2010 Apr; 41(4):503-12. PubMed ID: 20004946
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fluorescence in situ hybridization (FISH) analysis of melanocytic nevi and melanomas: sensitivity, specificity, and lack of association with sentinel node status.
    Fang Y; Dusza S; Jhanwar S; Busam KJ
    Int J Surg Pathol; 2012 Oct; 20(5):434-40. PubMed ID: 22561674
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fatty Acid Synthase and Acetyl-CoA Carboxylase Are Expressed in Nodal Metastatic Melanoma But Not in Benign Intracapsular Nodal Nevi.
    Saab J; Santos-Zabala ML; Loda M; Stack EC; Hollmann TJ
    Am J Dermatopathol; 2018 Apr; 40(4):259-264. PubMed ID: 28654463
    [TBL] [Abstract][Full Text] [Related]  

  • 12. PRAME expression by immunohistochemistry and reverse transcription quantitative PCR in conjunctival melanocytic lesions-a comprehensive clinicopathologic study of 202 cases and correlation of cytogenetics with PRAME expression in challenging conjunctival melanocytic lesions.
    Mudhar HS; Milman T; Stevenson S; Watson M; Kim J; Magan T; Salvi SM; Harley U; Lally SE; Shields CL
    Hum Pathol; 2023 Apr; 134():1-18. PubMed ID: 36804828
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Potential diagnostic utility of PRAME and p16 immunohistochemistry in melanocytic nevi and malignant melanoma.
    Bahmad HF; Oh KS; Alexis J
    J Cutan Pathol; 2023 Aug; 50(8):763-772. PubMed ID: 37114299
    [TBL] [Abstract][Full Text] [Related]  

  • 14. IMP-3 EXPRESSION IN BENIGN MELANOCYTIC NEVI, DYSPLASTIC NEVI AND MALIGNANT MELANOMA: PRELIMINARY FINDINGS IN BULGARIAN PATIENTS.
    Chokoeva AA; Ananiev J; Wollina U; Tana C; Lotti T; Cardoso JC; Tchernev G
    J Biol Regul Homeost Agents; 2015; 29(3):695-9. PubMed ID: 26403409
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Translation of a circulating miRNA signature of melanoma into a solid tissue assay to improve diagnostic accuracy and precision.
    Laar RV; King S; McCoy R; Saad M; Fereday S; Winship I; Uzzell C; Landgren A
    Biomark Med; 2021 Sep; 15(13):1111-1122. PubMed ID: 34184547
    [No Abstract]   [Full Text] [Related]  

  • 16. Fluorescence in situ hybridization as an ancillary method for the distinction of desmoplastic melanomas from sclerosing melanocytic nevi.
    Gerami P; Beilfuss B; Haghighat Z; Fang Y; Jhanwar S; Busam KJ
    J Cutan Pathol; 2011 Apr; 38(4):329-34. PubMed ID: 21323721
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Distinction of conjunctival melanocytic nevi from melanomas by fluorescence in situ hybridization.
    Busam KJ; Fang Y; Jhanwar SC; Pulitzer MP; Marr B; Abramson DH
    J Cutan Pathol; 2010 Feb; 37(2):196-203. PubMed ID: 20100177
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Common acquired melanocytic nevi, melanocytic dysplasia and malignant melanoma. A morphometric study.
    Santucci M; Urso C; Giannini A; Bondi R
    Appl Pathol; 1989; 7(2):111-5. PubMed ID: 2730799
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Loss of expression of protein kinase a regulatory subunit 1alpha in pigmented epithelioid melanocytoma but not in melanoma or other melanocytic lesions.
    Zembowicz A; Knoepp SM; Bei T; Stergiopoulos S; Eng C; Mihm MC; Stratakis CA
    Am J Surg Pathol; 2007 Nov; 31(11):1764-75. PubMed ID: 18059235
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Minichromosome maintenance protein expression in benign nevi, dysplastic nevi, melanoma, and cutaneous melanoma metastases.
    Boyd AS; Shakhtour B; Shyr Y
    J Am Acad Dermatol; 2008 May; 58(5):750-4. PubMed ID: 18249467
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.